A semiparametric approach to estimate rapid lung function decline in cystic fibrosis

Annals of Epidemiology

Volumn 23, Issue 12, 2013, Pages 771-777

  Szczesniak, Rhonda D ^a   McPhail, Gary L ^a   Duan, Leo L ^b   Macaluso, Maurizio ^a   Amin, Raouf S ^a   Clancy, John P ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Cystic fibrosis; Epidemiologic methods; Nonlinear models; Spline regression

Indexed keywords

ADULT; ADULTHOOD; ARTICLE; BURKHOLDERIA CEPACIA; CYSTIC FIBROSIS; DISEASE COURSE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PREDICTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SENSITIVITY ANALYSIS;

CYSTIC FIBROSIS; EPIDEMIOLOGIC METHODS; NONLINEAR MODELS; SPLINE REGRESSION;

ADOLESCENT; ADULT; CHILD; CYSTIC FIBROSIS; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LINEAR MODELS; LONGITUDINAL STUDIES; LUNG; MALE; REGRESSION ANALYSIS; UNITED STATES; YOUNG ADULT;

EID: 84888052528     PISSN: 10472797     EISSN: 18732585     Source Type: Journal    
DOI: 10.1016/j.annepidem.2013.08.009     Document Type: Article

References (35)

1. Farrell P.M. The prevalence of cystic fibrosis in the European Union. JCyst Fibros 2008, 7(5):450-453.
2. Gibson R.L., Burns J.L., Ramsey B.W. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003, 168(8):918-951.
3. Liou T.G., Elkin E.P., Pasta D.J., Jacobs J.R., Konstan M.W., Morgan W.J., et al. Year-to-year changes in lung function in individuals with cystic fibrosis. JCyst Fibros 2010, 9(4):250-256.
4. Vandenbranden S.L., McMullen A., Schechter M.S., Pasta D.J., Michaelis R.L., Konstan M.W., et al. Lung function decline from adolescence to young adulthood in cystic fibrosis. Pediatr Pulmonol 2012, 47(2):135-143.
5. Corey M., Farewell V. Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am J Epidemiol 1996, 143(10):1007-1017.
6. Lai H.J., Cheng Y., Cho H., Kosorok M.R., Farrell P.M. Association between initial disease presentation, lung disease outcomes, and survival in patients with cystic fibrosis. Am J Epidemiol 2004, 159(6):537-546.
7. Liou T.G., Adler F.R., Fitzsimmons S.C., Cahill B.C., Hibbs J.R., Marshall B.C. Predictive5-year survivorship model of cystic fibrosis. Am J Epidemiol 2001, 153(4):345-352.
8. Kerem E., Reisman J., Corey M., Canny G.J., Levison H. Prediction of mortality in patients with cystic fibrosis. NEngl J Med 1992, 326(18):1187-1191.
9. Konstan M.W., Morgan W.J., Butler S.M., Pasta D.J., Craib M.L., Silva S.J., et al. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. JPediatr 2007, 151(2):134-139. 9 e1.
10. Boelle P.Y., Viviani L., Busson P.F., Olesen H., Ravilly S., Stern M., et al. Reference percentiles for FEV1 and BMI in European children and adults with cystic fibrosis. Orphanet J Rare Dis 2012, 7(1):64.
11. CF-Foundation. Cystic Fibrosis Foundation Patient Registry: 2011 Annual Report 2012.
12. Mehta G., Macek M., Mehta A. Cystic fibrosis across Europe: EuroCareCF analysis of demographic data from 35 countries. JCyst Fibros 2010, 9(Suppl 2):S5-S21.
13. Morgan W.J., Butler S.M., Johnson C.A., Colin A.A., FitzSimmons S.C., Geller D.E., et al. Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada. Pediatr Pulmonol 1999, 28(4):231-241.
14. Zemel B.S., Jawad A.F., FitzSimmons S., Stallings V.A. Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry. JPediatr 2000, 137(3):374-380.
15. Schluchter M.D., Konstan M.W., Drumm M.L., Yankaskas J.R., Knowles M.R. Classifying severity of cystic fibrosis lung disease using longitudinal pulmonary function data. Am J Respir Crit Care Med 2006, 174(7):780-786.
16. Sanders D.B., Bittner R.C., Rosenfeld M., Redding G.J., Goss C.H. Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis. Pediatr Pulmonol 2011, 46(4):393-400.
17. Konstan M.W., Schluchter M.D., Xue W., Davis P.B. Clinical use of Ibuprofen is associated with slower FEV1 decline in children with cystic fibrosis. Am J Respir Crit Care Med 2007, 176(11):1084-1089.
18. Taylor-Robinson D., Whitehead M., Diderichsen F., Olesen H.V., Pressler T., Smyth R.L., et al. Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study. Thorax 2012, May 3.
19. Berhane K., Molitor N.T. ABayesian approach to functional-based multilevel modeling of longitudinal data: applications to environmental epidemiology. Biostatistics 2008, 9(4):686-699.
20. Dasenbrook E.C., Merlo C.A., Diener-West M., Lechtzin N., Boyle M.P. Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis. Am J Respir Crit Care Med 2008, 178(8):814-821.
21. Lambert P.C., Abrams K.R., Jones D.R., Halligan A.W., Shennan A. Analysis of ambulatory blood pressure monitor data using a hierarchical model incorporating restricted cubic splines and heterogeneous within-subject variances. Stat Med 2001, 20(24):3789-3805. [Comparative Study].
22. Gilboa S.M., Correa A., Alverson C.J. Use of spline regression in an analysis of maternal prepregnancy body mass index and adverse birth outcomes: does it tell us more than we already know?. Ann Epidemiol 2008, 18(3):196-205.
23. Brockwell PJ, Davis Richard A. Time series: theory and methods1991.
24. Ruppert D., Wand M.P., Carroll R.J. Semiparametric regression 2003, Cambridge University Press, Cambridge; New York.
25. Wang X., Dockery D.W., Wypij D., Fay M.E., Ferris B.G. Pulmonary function between 6 and 18 years of age. Pediatr Pulmonol 1993, 15(2):75-88.
26. Hankinson J., Odencrantz J.R., Fedan K.B. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999, 159:179-187.
27. Hastie T., Tibshirani R. Generalized additive models for medical research. Stat Methods Med Res 1995, 4(3):187-196.
28. Ngo L., Wand M.P. Smoothing with mixed model software. Journal of Statistical Software 2004, 9:1-54.
29. Crainiceanu C.M., Ruppert D. Restricted likelihood ratio tests in nonparametric longitudinal models. Stat Sinica 2004, 14(3):713-729.
30. Vandyke R., Ren Y., Sucharew H.J., Miodovnik M., Rosenn B., Khoury J.C. Characterizing maternal glycemic control: a more informative approach using semiparametric regression. JMatern Fetal Neonatal Med 2012, 25(1):15-19. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't].
31. McKay R.T., LeMasters G.K., Hilbert T.J., Levin L.S., Rice C.H., Borton E.K., et al. Along term study of pulmonary function among US refractory ceramic fibre workers. Occupational and Environmental Medicine 2011, 68(2):89-95.
32. Molenberghs G. Missing data in clinical studies 2007, John Wiley & Sons.
33. Verbeke G., Molenberghs G. Linear mixed models for longitudinal data 2000, Springer, New York.
34. Schechter M.S. Patient registry analyses: seize the data, but caveat lector. JPediatr 2008, 153(6):733-735.
35. Saracci R. Survival-related biases survive well. Int J Epidemiol 2007, 36(1):244-246.